There was a "miss" reported on the earnings vs what the analyst expectation was. This is so BOGUS!! The only reason for the so-called "miss" is because the ANALyst used the entire $60M Amgen payment as income. KITE correctly reported only a portion of this cash receipt as income under GAAP rules. That's it! There was no miss! Thank you all BOTS for giving us this gift of a share price. KITE will be back above $60 soon, as people start to focus on the real possibility of Amgen buying KITE and the tremendous pipeline possibilities.
Do you get paid to post here? Or are you a victim of child abuse by your step-dad and are trying to get even with the world?
Did anyone listen to me? Well now watch the huge overselling of all biotechs as the tide goes out. Wait until next Monday to pick up the jewels from the ashes.
You shouldn't group GILD in with the rest of the mentioned stock. Compared to the other stocks mentioned, GILD is really cheap here. Just look at the numbers for growth and PE and let me know why GILD is at less than half of the PEG of REGN or BIIB and at 20% PEG of CMG!!
He is all you say but he happens to be right about BIIB being a sell now. No stock goes parabolic in days and stays up no matter what the story. And, let's face it, BIIB will not benefit from the new Alzheimer drug until 2018!! Does this warrant a $25B run in market cap? I say not. Cramer is correct for once.
Anything less than $120 a share would be a travesty. EOG can be a lot higher than that when oil comes back.
The way shares are trading, writedowns look to be 90% of all assets on balance sheet. Anything less than 90% writedown and CHK will be off to the races and above $20 in days.
I hope so. The garbage would then be known quantity and thrown out. Only lean and productive assets will remain which mean huge productivity to be reflected on financials once oil and gas even begins to recover. Worst is if CHK does a small writedown and everyone realizes the problems are yet not quantified. Thanks for point this out CParker!!!
Yes but the stocks will anticipate it in advance and we will see moves up prior to seeing the effects of the production oversupply subsiding.
And don't think Icahn, Soros and other hedgies are not aware of this and want to pick up dirt cheap CHK equity soon...
Whatever happens, the sell off in CHK seems to be based on one thing, AMac wants cash and he's willing to sell at ANY price. CHK will be a lot higher in a few months once this unusual and short-term factor subsides.